Oscar Health Statistics
Total Valuation
Oscar Health has a market cap or net worth of $4.55 billion. The enterprise value is $2.27 billion.
Important Dates
The next confirmed earnings date is Wednesday, May 6, 2026, before market open.
| Earnings Date | May 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Oscar Health has 297.43 million shares outstanding. The number of shares has decreased by -1.30% in one year.
| Current Share Class | 261.84M |
| Shares Outstanding | 297.43M |
| Shares Change (YoY) | -1.30% |
| Shares Change (QoQ) | +9.25% |
| Owned by Insiders (%) | 2.92% |
| Owned by Institutions (%) | 54.29% |
| Float | 249.53M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 24.39 |
| PS Ratio | 0.39 |
| Forward PS | 0.24 |
| PB Ratio | 4.65 |
| P/TBV Ratio | 4.65 |
| P/FCF Ratio | 4.30 |
| P/OCF Ratio | 4.15 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.19 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 2.15 |
Financial Position
The company has a current ratio of 0.95, with a Debt / Equity ratio of 0.51.
| Current Ratio | 0.95 |
| Quick Ratio | 0.92 |
| Debt / Equity | 0.51 |
| Debt / EBITDA | n/a |
| Debt / FCF | 0.47 |
| Interest Coverage | -22.52 |
Financial Efficiency
Return on equity (ROE) is -44.35% and return on invested capital (ROIC) is -24.40%.
| Return on Equity (ROE) | -44.35% |
| Return on Assets (ROA) | -4.44% |
| Return on Invested Capital (ROIC) | -24.40% |
| Return on Capital Employed (ROCE) | -27.10% |
| Weighted Average Cost of Capital (WACC) | 13.68% |
| Revenue Per Employee | $5.08M |
| Profits Per Employee | -$192,256 |
| Employee Count | 2,305 |
| Asset Turnover | 2.10 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Oscar Health has paid $5.61 million in taxes.
| Income Tax | 5.61M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +21.64% in the last 52 weeks. The beta is 1.93, so Oscar Health's price volatility has been higher than the market average.
| Beta (5Y) | 1.93 |
| 52-Week Price Change | +21.64% |
| 50-Day Moving Average | 13.22 |
| 200-Day Moving Average | 15.93 |
| Relative Strength Index (RSI) | 66.43 |
| Average Volume (20 Days) | 6,653,292 |
Short Selling Information
The latest short interest is 26.50 million, so 8.91% of the outstanding shares have been sold short.
| Short Interest | 26.50M |
| Short Previous Month | 25.77M |
| Short % of Shares Out | 8.91% |
| Short % of Float | 10.62% |
| Short Ratio (days to cover) | 3.89 |
Income Statement
In the last 12 months, Oscar Health had revenue of $11.70 billion and -$443.15 million in losses. Loss per share was -$1.69.
| Revenue | 11.70B |
| Gross Profit | 1.68B |
| Operating Income | -396.36M |
| Pretax Income | -437.30M |
| Net Income | -443.15M |
| EBITDA | -367.47M |
| EBIT | -396.36M |
| Loss Per Share | -$1.69 |
Full Income StatementBalance Sheet
The company has $3.99 billion in cash and $498.80 million in debt, with a net cash position of $2.28 billion or $7.65 per share.
| Cash & Cash Equivalents | 3.99B |
| Total Debt | 498.80M |
| Net Cash | 2.28B |
| Net Cash Per Share | $7.65 |
| Equity (Book Value) | 980.74M |
| Book Value Per Share | 3.29 |
| Working Capital | -249.18M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $1.09 billion and capital expenditures -$36.37 million, giving a free cash flow of $1.06 billion.
| Operating Cash Flow | 1.09B |
| Capital Expenditures | -36.37M |
| Depreciation & Amortization | n/a |
| Net Borrowing | 371.12M |
| Free Cash Flow | 1.06B |
| FCF Per Share | $3.56 |
Full Cash Flow StatementMargins
Gross margin is 14.38%, with operating and profit margins of -3.39% and -3.79%.
| Gross Margin | 14.38% |
| Operating Margin | -3.39% |
| Pretax Margin | -3.74% |
| Profit Margin | -3.79% |
| EBITDA Margin | -3.14% |
| EBIT Margin | -3.39% |
| FCF Margin | 9.05% |
Dividends & Yields
Oscar Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.30% |
| Shareholder Yield | 1.30% |
| Earnings Yield | -9.74% |
| FCF Yield | 23.27% |
Analyst Forecast
The average price target for Oscar Health is $17.00, which is 11.18% higher than the current price. The consensus rating is "Hold".
| Price Target | $17.00 |
| Price Target Difference | 11.18% |
| Analyst Consensus | Hold |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |
